Pharmacy Practice-Granada最新文献

{"title":"The influence of SARS-COV-2 pandemic in the pharmaceutical service in ALBANIA.","authors":"Irsida Mehmeti,&nbsp;Silvi Bozo,&nbsp;Entela Kostrista,&nbsp;Eftiola Pojani","doi":"10.18549/PharmPract.2023.1.2750","DOIUrl":"10.18549/PharmPract.2023.1.2750","url":null,"abstract":"<p><strong>Objective: </strong>In the second year of the COVID-19 pandemic, the role of the pharmacists was confirmed as central at the territorial level. The purpose of this study was to assess knowledge, attitudes, and practices of pharmacists in Albania, critical changes in the Albanian pharmaceutical market during the COVID-19 pandemic and evaluate factors influencing the quality of the pharmaceutical service.</p><p><strong>Methods: </strong>A nationwide survey was conducted, using an online questionnaire targeting Albanian pharmacists during 2021.</p><p><strong>Results: </strong>Most of the respondents were females (86.2%), belonged to the 30-39 age group (51.7%) and worked in community pharmacies (73%). Although most of the respondents did participate in training courses (62.8%), only about 38% of them had good knowledge about COVID-19 (score 5/8). Moreover, the level of knowledge increases the possibility to apply the rules. 65% of the pharmacists who were very afraid of getting infected with COVID -19, stated that they followed the WHO rules compared to 37 % of those who were not afraid. Regarding the medicines offered, 64% of the respondents claimed that there have been difficulties in ensuring the adequate medicines during the pandemic. Furthermore, although 61% of the pharmacists declared that the price of medicines during the pandemic has not changed, 58% of them thought that the revenues of all pharmaceutical sectors have risen.</p><p><strong>Conclusion: </strong>From this study it is concluded that although the pharmacists in Albania have demonstrated strength, professionality, and commitment to offer pharmaceutical service to the highest level, they faced numerous challenges during this difficult time. In the future, the pharmacist's role can be extended in the community to provide successful medical service and their collaboration within and between pharmacists and physicians is essential.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2750"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d4/74/pharmpract-21-2750.PMC10117356.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the clinical application of the immune cells' ratios and inflammatory markers in the diagnosis of inflammatory bowel disease.","authors":"Mamoon M D Al-Rshaidat,&nbsp;Shaima Al-Sharif,&nbsp;Assem Al Refaei,&nbsp;Nour Shewaikani,&nbsp;Ahmad R Alsayed,&nbsp;Yaser M Rayyan","doi":"10.18549/PharmPract.2023.1.2755","DOIUrl":"10.18549/PharmPract.2023.1.2755","url":null,"abstract":"<p><strong>Objective: </strong>Inflammatory Bowel Diseases (IBDs) are chronic inflammatory conditions of the gastrointestinal tract, including Crohn's disease (CD) and ulcerative colitis (UC). Developing methods for effective screening and diagnosis is extremely needed. Accordingly, this study aims to evaluate the potential of immune cells ratios in the diagnosis of IBD.</p><p><strong>Methods: </strong>This case-control study includes data from Jordan University Hospital (JUH) medical records for IBD patients with age- and gender-matched healthy controls.</p><p><strong>Results: </strong>This study included 46 participants, of which 56.52% had IBD, 54.35% were males, with insignificant differences in sex, age, and body mass index (BMI) between IBD patients and controls (p>0.05). In the CD group, the variables with the highest sensitivity and specificity (HSS) were neutrophil-to-lymphocyte (NLR) (75%, 80%) and platelet-to-lymphocytes (PLR) (75%, 90%), in UC group; mean corpuscular hemoglobin (MCH) (80%, 80%). In CD group, the combinations giving the HSS were PLR+NLR (76%, 90.9%), C-reactive protein (CRP)+PLR (76%, 90.9%), and CRP+NLR (73.07%, 90%). In UC group, the combinations giving the HSS were erythrocyte sedimentation rate (ESR)+PLR (76.9%, 100%), PLR+MCH (74.07%, 100%), PLR+CRP (71.42%, 100%), and PLR+NLR (71.42%, 100%). Regression analysis identified five different combinations of significance in the diagnosis of CD and UC. Higher Youden's index was used and defined the most beneficial clinical combinations as NLR+PLR and CRP+PLR for CD, whereas ESR+PLR for UC.</p><p><strong>Conclusion: </strong>Implications to our study include the clinical application of immune cell ratios, inflammatory markers, and their different combinations along with patients' history and physical examination findings for easier, faster, and more cost-effective diagnosis of IBDs.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2755"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/d3/pharmpract-21-2755.PMC10117338.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effects and safety of high dose vitamin D3 in hemodialysis patients.","authors":"Adnane Guella,&nbsp;Abduelmula R Abduelkarem,&nbsp;Mohammed M Hassanein","doi":"10.18549/PharmPract.2023.1.2773","DOIUrl":"10.18549/PharmPract.2023.1.2773","url":null,"abstract":"<p><strong>Background: </strong>Different studies have shown that hemodialysis patients require higher doses of Vitamin D3 (VD3) than the general population to achieve satisfactory replenishment. This study aims to assess the safety of such practice and its benefits on some of the parameters of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD).</p><p><strong>Methods: </strong>A single-center clinical trial assessing the benefits of high dose VD3 in hemodialysis patients. The dose of VD3 (300,000 IU) was administered orally and monthly from April to December 2020 (9 months) at the dialysis unit. The data analyzed were blood levels of calcium, phosphorus, alkaline phosphatase, 25(OH)D, 1,25(OH)2D and intact parathyroid hormone (iPTH) done every three months.</p><p><strong>Results: </strong>We could recruit a cohort of 23 patients. Blood levels of 25(OH)D increased significantly in 82.6% of the patients to above 30 ng/ml. A similar effect was observed with 1, 25(OH)2D levels. iPTH levels decreased significantly when levels of 25(OH)D exceeded 30ng/ml at the end of the nine months. Vitamin D serum levels were typically measured immediately before the next monthly dose was administered. Blood levels of calcium, phosphorus, and alkaline phosphatase were stable during the study period. No events of hypercalcemia were reported, and no patient discontinued the monthly VD3 supplementation.</p><p><strong>Conclusion: </strong>Monthly administration of a high dose of VD3 over a long period of nine months in hemodialysis patients was found to be safe and beneficial in VD3 replenishment. It also allowed a significant decrease in iPTH levels. Further studies are warranted to identify the therapeutic target level of 25(OH)D in hemodialysis patients, allowing beneficial effects on iPTH.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2773"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2d/32/pharmpract-21-2773.PMC10117363.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perception and attitudes toward COVID- 19 vaccines in Jordan: lessons for future pandemics.","authors":"Dalal Alnatour,&nbsp;Razan I Nassar,&nbsp;Yara Salhi,&nbsp;Samar Thiab,&nbsp;Ahmad R Alsayed","doi":"10.18549/PharmPract.2023.1.2781","DOIUrl":"10.18549/PharmPract.2023.1.2781","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess Jordanians' perception and attitudes toward COVID-19 vaccines authorized for use in Jordan. Another objective was to evaluate the population's confidence in vaccine efficacy, their fears of the vaccines, and their perceptions and attitudes after vaccination.</p><p><strong>Methods: </strong>This cross-sectional study was conducted over four months (August 2021- December 2021) and included the general Jordanian population above 18 years old.</p><p><strong>Results: </strong>A total of 398 participants were included in the study, with the majority (around 81.0%) received at least one dose of any of COVID-19 vaccines approved for use in Jordan. Most non-vaccinated participants (67.4%) were either unwilling to receive the COVID-19 vaccine or unsure. The main reasons for receiving the vaccine were: family protection, self-protection, global efforts to fight the virus and local restrictions, with some variability between vaccinated and non-vaccinated. The major reasons for fear of COVID-19 vaccines were limited research, vaccine effectiveness, and vaccine side effects. Pfizer-BioNTech vaccine was the most trusted vaccine by vaccinated and non-vaccinated participants (47.8% and 57.9%, respectively), and Oxford-AstraZeneca was the most feared by them (42.2% and 57.9%, respectively). Internet websites (>85.0%), social media platforms (>70.0%), relatives and friends (>69.0%), and news applications (>60.0%) were the major sources of information about the COVID-19 vaccines among participants.</p><p><strong>Conclusion: </strong>Our results revealed that hesitation in receiving the vaccine remains a challenge in Jordan, as in other countries. The findings also show that participants, regardless of their vaccination status, had many concerns about the four types of vaccines approved for use in Jordan during the study conduction period. Moreover, the participants' perceptions and attitudes towards the vaccines were variable between vaccinated and non-vaccinated participants and were variable for the four types of vaccines.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2781"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9e/a6/pharmpract-21-2781.PMC10117358.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Psychological effects on self-medication during the pandemic COVID-19 in WP Labuan: A development of questionnaire and pilot-testing.","authors":"Michelle L Tan,&nbsp;Shamsur Rahman,&nbsp;Freddie Robinson,&nbsp;Mohd Hijaz Mohd Sani","doi":"10.18549/PharmPract.2023.1.2779","DOIUrl":"10.18549/PharmPract.2023.1.2779","url":null,"abstract":"<p><strong>Introduction: </strong>Self-Medication, which is a practice to self-treat using medicine without consulting a medical practitioner or a doctor, is a common practice and the Pandemic Covid-19 may have caused people to resort to self-medication in order to reduce the infectivity of the Covid-19.</p><p><strong>Objective: </strong>To validate and develop an instrument in Bahasa Melayu to assess the psychological distress and self-medication during pandemic Covid-19 in WP Labuan.</p><p><strong>Methods: </strong>A pilot study was conducted among 160 participants in WP Labuan. Reliability testing on internal consistency and content validity was performed on the adapted Covid-19 Peritraumatic Distress Index (CPDI) as well as domain on knowledge, practice and attitude of self-medication.</p><p><strong>Result: </strong>A panel of seven experts evaluated the research instrument for content validity and it was found to have good content item validity. The CPDI domain showed good internal consistency of Cronbach's Alpha of 0.919. The mean (SD) CPDI score of the respondents in WP Labuan was 32.55 (15.98). 64.2% of the respondents experienced psychological distress. The variable for Area (town/countryside) was found to be statistically significant (p<0.05) to be associated with self-medication during the pandemic.</p><p><strong>Conclusion: </strong>The instrument established sound reliability and validity and therefore, can be an effective tool for assessing psychological distress and self-medication in the Malaysian population.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2779"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b0/02/pharmpract-21-2779.PMC10117300.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9756188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The psychological impact of COVID-19 restrictions on undergraduate students in Jordan.","authors":"Saif Aldeen Jaber","doi":"10.18549/PharmPract.2023.1.2786","DOIUrl":"10.18549/PharmPract.2023.1.2786","url":null,"abstract":"<p><strong>Introduction: </strong>COVID-19 has spread all over the world since December 2019 causing millions of deaths. The pandemic has not only caused a risk of death from the infection but also caused psychological unbearable stress on people due to restrictions.</p><p><strong>Methodology: </strong>A sample of students from Jordanian different universities using a questionnaire has been conducted. The questionnaire has been prepared with different personal questions to correlate the answers with anger episodes/week.</p><p><strong>Results: </strong>750 students participated and indicated that 13.6% and 20.9% of students have been facing severe anger episodes (>2) or moderate anger episodes (1-2) every week. Moreover, stable family income ((OR=0.901, 95%CI = 0.799-0.998), studying at private universities (OR=0.0.724, 95%CI = 0.627-.833) and living in the city centre (OR=0.0.698, 95%CI = 0.492-0.897) have a protective effect on anger episodes. However, student gender and study level have no significant effect on anger severity.</p><p><strong>Conclusion: </strong>Undergraduate and master's students have faced severe conditions during the Covid-19 lockdown which had a direct psychological effect on them. Students' situations and students' study levels should be taken into consideration to provide a mental health program for whom under huge stress.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2786"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/81/pharmpract-21-2786.PMC10117323.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9756190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Co-infection of COVID-19 patients with atypical bacteria: A study based in Jordan.","authors":"Ahmad R Alsayed,&nbsp;Luai Hasoun,&nbsp;Heba A Khader,&nbsp;Mahmoud S Abu-Samak,&nbsp;Laith Mh Al-Shdifat,&nbsp;Basheer Al-Shammari,&nbsp;Mohammed Al Maqbali","doi":"10.18549/PharmPract.2023.1.2753","DOIUrl":"10.18549/PharmPract.2023.1.2753","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this work was to know the prevalence of <i>Chlamydophila pneumoniae</i> and <i>Mycoplasma pneumoniae</i> in coronavirus disease 2019 (COVID-19) patients in Jordan. Also, to assess a TaqMan real-time polymerase chain reaction (PCR) assay in detecting these two bacteria.</p><p><strong>Methods: </strong>This is a retrospective study performed over the last five months of the 2021. All nasopharyngeal specimens from COVID-19 patients were tested for C. pneumonia, and M. pneumoniae. The <i>C. pneumoniae</i> Pst-1 gene and <i>M. pneumoniae</i> P1 cytadhesin protein gene were the targets.</p><p><strong>Results: </strong>In this study, 14 out of 175 individuals with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (8.0%) were co-infected with <i>C. pneumoniae</i> or <i>M. pneumoniae</i>. Co-infection with SARS-CoV-2 and <i>C. pneumoniae</i> was reported in 5 (2.9%) patients, while 9 (5.1%) patients had <i>M. pneumoniae</i> and SARS-CoV-2 co-infection. The mean (± std) of the correlation coefficient of the calibration curve for real-time PCR analysis was -0.993 (± 0.001) for <i>C. pneumoniae</i> and -0.994 (± 0.003) for <i>M. pneumoniae</i>. The mean amplification efficiencies of <i>C. pneumoniae</i> and <i>M. Pneumoniae</i> were 187.62% and 136.86%, respectively.</p><p><strong>Conclusion: </strong>In this first study based in Jordan, patients infected with COVID-19 have a low rate of atypical bacterial co-infection. However, clinicians should suspect co-infections with both common and uncommon bacteria in COVID-19 patients. Large prospective investigations are needed to give additional insight on the true prevalence of these co-infections and their impact on the clinical course of COVID-19 patients.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2753"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/0f/pharmpract-21-2753.PMC10117357.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9756194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical Associations with the differences in rivaroxaban dosing in patients with atrial fibrillation stratified by three renal function formulae.","authors":"Juhaina Salim Al-Maqbali,&nbsp;Abdullah M Al Alawi,&nbsp;Maria Al-Adawi,&nbsp;Zubaida Al-Falahi,&nbsp;Asia Al-Azizi,&nbsp;Kholoud Al Badi,&nbsp;Mohamed Al Rawahi","doi":"10.18549/PharmPract.2023.1.2758","DOIUrl":"10.18549/PharmPract.2023.1.2758","url":null,"abstract":"<p><strong>Background: </strong>Clinical trials used Cockcroft-Gault (CG) formula to calculate the estimated glomerular filtration rate (eGFR) in order to dose rivaroxaban for patients with atrial fibrillation (AF).</p><p><strong>Objectives: </strong>The aim of this study is to evaluate rivaroxaban dosing appropriateness in patients with AF with or without renal impairment based on the CG formula and other formulae, including Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and the isotope dilution mass spectrometry (IDMS) traceable Modification of Diet in Renal Disease (MDRD) Study equation and the associated clinical outcomes.</p><p><strong>Methodology: </strong>A retrospective cohort study conducted at Sultan Qaboos University Hospital (SQUH) from 1st January 2016 to 31st December 2020, included all adult patients (≥ 18 years) treated with rivaroxaban for AF and followed up for one year after starting the treatment.</p><p><strong>Results: </strong>Based on the CG formula, the rivaroxaban dose was inappropriately prescribed in 27% of the patients (21% overdosed and 6% underdosed). Higher baseline creatinine (P=0.0014) and concurrent use of antiplatelet therapy (P<0.001) were associated with the tendency to rivaroxaban overdosing. Higher Body Mass Index (BMI) (P=0.002), female sex (P=0.032), and CKD (P=0.003) were associated with rivaroxaban underdosing. The degree of agreement between the renal function tests when comparing MDRD vs CG and CKD-EPI vs CG in terms of estimated glomerular filtration rate/creatine clearance (eGFR/CrCl) calculation was moderate (κ=0.46) and poor (κ=0.00), respectively, while, in terms of rivaroxaban dose appropriateness was almost perfect (κ=0.82) and substantial (κ=0.77). Clinical outcomes measured by stroke and bleeding events were not significantly different according to the appropriateness of the rivaroxaban dose.</p><p><strong>Conclusion: </strong>This study has shown a relatively high consistency with the gold standard in dosing rivaroxaban in AF patients using CG formula. Treatment efficiency and safety were not affected by the proportion of dose inappropriateness found in this cohort.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2758"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/b1/pharmpract-21-2758.PMC10117315.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9387594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The socio-demographic and lifestyle characteristics associated with quality of life among diabetic patients in Lebanon: a cross-sectional study.","authors":"Diana Dakroub,&nbsp;Fouad Sakr,&nbsp;Mariam Dabbous,&nbsp;Nada Dia,&nbsp;Jana Hammoud,&nbsp;Aya Rida,&nbsp;Aya Ibrahim,&nbsp;Hala Fahs,&nbsp;Sahar Obeid,&nbsp;Souheil Hallit,&nbsp;Diana Malaeb","doi":"10.18549/PharmPract.2023.1.2775","DOIUrl":"10.18549/PharmPract.2023.1.2775","url":null,"abstract":"<p><strong>Objective: </strong>Diabetes mellitus (DM) is a chronic non-communicable endocrine disease that has a considerable impact on both the health and quality of life (QoL) of patients. This study aimed to investigate the sociodemographic factors associated with the quality of life among the Lebanese population with DM.</p><p><strong>Methods: </strong>A cross-sectional study that enrolled 125 diabetic patients aged ≥18, was conducted between January and June of 2021. The validated Arabic version of the Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaire is utilized by all patients to measure the quality of life (QoL). A logistic regression was then performed.</p><p><strong>Results: </strong>The life domains \"freedom to eat\" and \"freedom to drink\", were the most negatively impacted by diabetes. According to the multivariate analysis monthly income OR 3.4, 95 % CIs 1.25 -9.6, P = 0.017, educational level (OR) 0.2, 95 % CIs 0.07 -0.89, HbA1c (OR) 7, 95 % CIs 1.5 -32.35, and FBG [odds ratio (OR) 1.01, 95 % (CIs) 1.004 -1.021, P = 0.005] were independently associated with impaired QOL.</p><p><strong>Conclusion: </strong>The study showed that diabetes generally had a negative impact on QoL. The findings also suggest that certain sociodemographic factors, such as monthly income and educational level along with clinical parameters like HbA1c, might be associated with a lower quality of life among Lebanese diabetic patients.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2775"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/59/8b/pharmpract-21-2775.PMC10117344.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9444366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence and factors associated with potentially inappropriate medication and medication complexity for older adults in the emergency department of a secondary teaching hospital in Indonesia.","authors":"Khusnul Fitri Hamidah,&nbsp;Mahardian Rahmadi,&nbsp;Farah Meutia,&nbsp;Prihatma Kriswidyatomo,&nbsp;Firman Suryadi Rahman,&nbsp;Zamrotul Izzah,&nbsp;Bambang Subakti Zulkarnain,&nbsp;Leopold N Aminde,&nbsp;Christopher Paul Alderman,&nbsp;Yulistiani,&nbsp;Budi Suprapti","doi":"10.18549/PharmPract.2022.4.2735","DOIUrl":"10.18549/PharmPract.2022.4.2735","url":null,"abstract":"<p><strong>Background: </strong>Older adults experience progressive decline in various organs and changes in pharmacokinetics and pharmacodynamics of the drugs in the body which lead to an increased risk of medication-related problems. Potentially inappropriate medications (PIMs) and medication complexity are key factors contributing to adverse drug events in the emergency department (ED).</p><p><strong>Objective: </strong>To estimate the prevalence and investigate the risk factors of PIMs and medication complexity among older adults admitted to the ED.</p><p><strong>Methods: </strong>A retrospective observational study was conducted among patients aged > 60 years admitted to the ED of Universitas Airlangga Teaching Hospital in January - June 2020. PIMs and medication complexity were measured using the 2019 American Geriatrics Society Beers Criteria® and Medication Regimen Complexity Index (MRCI), respectively.</p><p><strong>Results: </strong>A total of 1005 patients were included and 55.0% (95% confidence interval [CI]: 52 - 58%) of them received at least one PIM. Whereas, the pharmacological therapy prescribed to older adults had a high complexity index (mean MRCI 17.23 + 11.15). Multivariate analysis showed that those with polypharmacy (OR= 6.954; 95% CI: 4.617 - 10.476), diseases of the circulatory system (OR= 2.126; 95% CI: 1.166 - 3.876), endocrine, nutritional, and metabolic diseases (OR= 1.924; 95% CI: 1.087 - 3.405), and diseases of the digestive system (OR= 1.858; 95% CI: 1.214 - 2.842) had an increased risk of receiving PIM prescriptions. Meanwhile, disease of the respiratory system (OR = 7.621; 95% CI: 2.833 - 15.150), endocrine, nutritional and metabolic diseases (OR = 6.601; 95% CI: 2.935 - 14.847), and polypharmacy (OR = 4.373; 95% CI: 3.540 - 5.401) were associated with higher medication complexity.</p><p><strong>Conclusion: </strong>In our study, over one in every two older adults admitted to the ED had PIMs, and a high medication complexity was observed. Endocrine, nutritional and metabolic disease was the leading risk factors for receiving PIMs and high medication complexity.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"20 4","pages":"2735"},"PeriodicalIF":2.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f2/8a/pharmpract-20-2735.PMC9891774.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10795145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}